Loading...
Liquidia Corporation
LQDA•NASDAQ
Healthcare
Biotechnology
$32.13
$-2.92(-8.33%)
U.S. Market is Open • 12:28Liquidia Corporation (LQDA) AI-Powered Stock Analysis
See how Liquidia Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLiquidia Corporation (LQDA) Stock Overall Grade
Liquidia Corporation’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Liquidia Corporation's overall stock rating.
Forecast
AScore
89/100Financial Growth
C+Score
55/100Fundamental Growth
C+Score
51/100Key Ratios
CScore
42/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
B+Score
73/100Liquidia Corporation (LQDA) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 89/100 (A), reflecting high confidence in its potential. Financial Growth (55/100, C+) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (42/100, C) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (73/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Liquidia Corporation stock grade, including financials, comparisons, and forecasts.